Craig Waugh
Overview
Explore the profile of Craig Waugh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Greenhough H, Waugh C, van Ginkel R, Bowater J, Kaur G, Oakly J, et al.
Sci Rep
. 2025 Mar;
15(1):7430.
PMID: 40032889
Bioactive venoms and toxins are emerging as a promising source of drug leads. Optimized through evolution, these compounds display remarkable selectivity and ligand affinity toward a range of relevant pharmacological...
2.
Tang J, Cait A, OSullivan D, Waugh C, van Ginkel R, Passfield E, et al.
Biochem Pharmacol
. 2025 Feb;
235:116805.
PMID: 39993611
Indigo naturalis (IN) is a natural product extensively used as a traditional Chinese medicine due to its pharmacological properties. While IN has been proposed to exert its activity, at least...
3.
Mules T, Tang J, Vacca F, Yumnam B, Schmidt A, Lavender B, et al.
Immunol Cell Biol
. 2024 Apr;
102(5):396-406.
PMID: 38648862
Increased permeability of the intestinal epithelial layer is linked to the pathogenesis and perpetuation of a wide range of intestinal and extra-intestinal diseases. Infecting humans with controlled doses of helminths,...
4.
Hamid M, Cespedes P, Jin C, Chen J, Gileadi U, Antoun E, et al.
Nat Immunol
. 2024 Apr;
25(5):834-846.
PMID: 38561495
Cancer remains one of the leading causes of mortality worldwide, leading to increased interest in utilizing immunotherapy strategies for better cancer treatments. In the past decade, CD103 T cells have...
5.
Yin Z, Chen J, Lu Y, Wang B, Godfrey L, Mentzer A, et al.
Cell Rep
. 2023 May;
42(5):112470.
PMID: 37141092
Most existing studies characterizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cell responses are peptide based. This does not allow evaluation of whether tested peptides are processed and presented...
6.
Peng Y, Felce S, Dong D, Penkava F, Mentzer A, Yao X, et al.
Nat Immunol
. 2021 Dec;
23(1):50-61.
PMID: 34853448
NP-B*07:02-specific CD8 T cell responses are considered among the most dominant in SARS-CoV-2-infected individuals. We found strong association of this response with mild disease. Analysis of NP-B*07:02-specific T cell clones...
7.
Boundy M, Harwood D, Tommasi E, Burger E, van Ginkel R, Waugh C, et al.
Toxicon
. 2021 Nov;
204:56-63.
PMID: 34742781
Saxitoxin and its derivatives, the paralytic shellfish toxins (PSTs), are well known to be toxic to humans, and maximum permitted levels in seafood have been established by regulatory authorities in...
8.
Hamid M, Yao X, Waugh C, Rosendo-Machado S, Li C, Rostron T, et al.
Front Immunol
. 2020 Mar;
11:310.
PMID: 32194559
Interferon gamma (IFNγ) supports effector responses of CD8 cytotoxic T lymphocytes (CTLs) and is a surrogate marker for detection of antigen-specific T cells. Here, we show that tumor-specific CTL clones...
9.
Hamid M, Colin-York H, Khalid-Alham N, Browne M, Cerundolo L, Chen J, et al.
Cancer Immunol Res
. 2019 Nov;
8(2):203-216.
PMID: 31771983
Enrichment of CD103 tumor-infiltrating T lymphocytes (TIL) is associated with improved outcomes in patients. However, the characteristics of human CD103 cytotoxic CD8 T cells (CTL) and their role in tumor...
10.
Li X, Wang R, Fan P, Yao X, Qin L, Peng Y, et al.
Front Oncol
. 2019 Nov;
9:1066.
PMID: 31709176
Cancer patients often display dysfunctional antitumor T-cell responses. Because noteworthy benefits of immune checkpoint pathway blockade, such as programmed cell death protein 1 (PD-1) inhibitors, have been achieved in multiple...